Difference between revisions of "Talk:Zhang Feiyuan"
| Line 3: | Line 3: | ||
'''[[About Oroboros]]''' | '''[[About Oroboros]]''' | ||
</div> | </div> | ||
:<big><big>'''[http://wiki.oroboros.at/images/4/44/MiPNet14.10_O2k-Top10.pdf Top 10 reasons for Oroboros]'''</big></big> | |||
<br> | |||
<div style="background-color:#ffffff;padding-top:0.2em;padding-right: 0.4em;padding-bottom: 0.2em;padding-left: 0.4em;"> | <div style="background-color:#ffffff;padding-top:0.2em;padding-right: 0.4em;padding-bottom: 0.2em;padding-left: 0.4em;"> | ||
| Line 68: | Line 73: | ||
TRACT (http://bioblast.at/index.php/TRACT) and TRANSMIT (http://bioblast.at/index.php/TRANSMIT) are projects involving oesophageal and prostate cancer research. | TRACT (http://bioblast.at/index.php/TRACT) and TRANSMIT (http://bioblast.at/index.php/TRANSMIT) are projects involving oesophageal and prostate cancer research. | ||
Revision as of 16:06, 5 February 2018
Oroboros Instruments is strongly engaged in cancer research sending you an alert on the World Cancer Day.
Β» https://www.uicc.org/what-we-do/convening/world-cancer-day
In the course of cancer progression, reprogramming of cell metabolism points out to mitochondrial adjustments to the oncological state or may involve mitochondrial dysfunction. Metabolism and mitochondria are therefore in the focus of research as potential targets for novel anticancer therapies.
Β» O2k-Publications on cancer: http://wiki.oroboros.at/index.php/O2k-Publications:_Cancer
| Mitochondria and cancer |
1. Metabolic reprogramming
2. Mitochondrial DNA damage
3. Mitochondrial enzyme deficiency
4. Oxidative stress
5. Altered calcium homeostasis
6. Altered ATP synthesis
| High-Resolution FluoRespirometry β Two in one |
| Combined measurements
1. Mitochondrial respiration | Applicable to all types of samples
1. Intact and permeabilized cells, including blood cells |
| Marie SkΕodowska-Curie PhD Projects |
TRACT (http://bioblast.at/index.php/TRACT) and TRANSMIT (http://bioblast.at/index.php/TRANSMIT) are projects involving oesophageal and prostate cancer research.
